Synthesis and biological evaluations of N-(substituted benzoylamino)-5- carbethoxymethyl-1,2,3,6-tetrahydropyridines as potential anti-inflammatory and hyperglycemic agents

Medicinal Chemistry Research

Volumn 9, Issue 2, 1999, Pages 133-148

  Okoro, Cosmas O ^a   Yoon, Kyoung Jin P ^a   Wilson, Tiffany L ^a   Onubogu, Udobi C ^a   Eckford, Tanya S ^a   Redda, Kinfe K ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PIPERIDEINE DERIVATIVE; ANTIINFLAMMATORY AGENT; CHLORPROPAMIDE; HYPERGLYCEMIC AGENT; INDOMETACIN; N (4' METHYLBENZOYLAMINO) 5 CARBETHOXYMETHYL 1,2,3,6 TETRAHYDROPYRIDINE; N (BENZOYLAMINO) 5 CARBETHOXYMETHYL 1,2,3,6 TETRAHYDROPYRIDINE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; HYPERGLYCEMIA; INFLAMMATION; NONHUMAN; PAW EDEMA; RAT; RHEUMATIC DISEASE;

EID: 0032957829     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1. Coutts, R. T.; Casay, A. F. In Pyridine and Reduced Pyridines of Pharmacological Interest, Vol. 14; Abramovitch, R. A., Ed.; Interscience: New York, 1975; Chapter XVI, pp 445-524.
2. 2. Ferles M.; Pliml, J. In Advances in Heterocyclic Chemistry, Vol 12; Katritzky, A. R.; Boulton, A. J., Eds.; Academic: New York, 1970; pp 43-101.
3. 3. Yates, F. S. In Comprehensive Heterocyclic Chemistry, Vol. 2; Katritzky, A. R.; Ress, A. W., Eds.; Pergamon: New York, 1984, pp 511-524.
4. 4. Fries, D. S.; Vries, J. D.; Hazelhoff, B.; Horn, A. S. J. Med. Chem. 1986, 29, 424-427.
5. 5. Gessner, W.; Brossi, A.; Shen, R. S.; Abell, C. W. J. Med. Chem. 1985, 28, 311-317.
6. 6. Knaus, E. E.; Redda, K. K. J. Heterocyclic Chem., 1976, 13, 1237-1240.
7. 7. Knaus, E. E.; Redda, K. K.; Waldelmaier, F. W. U. S. Patent 4, 088,653, (1978); Chem. Abstr., 89, 6617k (1978).
8. 7. Knaus, E. E.; Redda, K. K.; Waldelmaier, F. W. U. S. Patent 4, 088,653, (1978); Chem. Abstr., 89, 6617k (1978).
9. 8. Knaus, E. E.; Redda, K. K.; Waldelmaier, F. W. Canadian Patent 1,120,930, (1982); Chem. Abstr., 97, 38859c (1982).
10. 8. Knaus, E. E.; Redda, K. K.; Waldelmaier, F. W. Canadian Patent 1,120,930, (1982); Chem. Abstr., 97, 38859c (1982).
11. 9. Redda, K. K.; Melles, H.; Kode, N. R. J. Heterocyclic Chem., 1990, 27, 1041-1046.
12. 10. Redda, K. K.; Kode, N. R.; Heiman, A. S.; Onayemi, F. Y.; Clark, J. B. Chem. Pharm. Bull., 1991, 39, 786-791.
13. 11. Kode, N. R.; Redda, K. K.; Onayemi, F. Y.; Melles, H.; Choi, J. Heterocyclic Chem., 1995, 32, 307-315.
14. 12. Choi, J.; Wilson, T. L.; Ly, A. M.; Okoro, C. O.; Onubogu, U. C.; Redda, K. K. Med. Chem. Res., 1995, 5, 281-295.
15. 13. Redda, K. K.; Rao, K. N.; Heiman, A. S.; Melles, H. J. Pharm. Sc. 1992, 81, 463-466.
16. 14. Yeung, J. M; Corleto, L. A.; Knaus, E. E. J. Med. Chem. 1982, 25, 720-723.
17. 15. Tamura, Y.; Minamikawa, J.; Kita, Y.; Kim, J. H.; Ikeda, M. Tetrahedron, 1973, 29, 1063-1068.
18. 16. CAUTION: o-Mesitylenesulfonylhydroxylamine 2 (MSH) is unstable; (a) Capino, L. A.; J. Am. Chem. Soc., 1960, 82, 3133-3135.
19. MSH is also potentially explosive, (b) Ning, R. Y. C & EN News, Dec. 17, 1973, 36-37.
20. 17. Winter, C. A.; Risley, E. A.; Nuss, G. W. Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
21. 18. Fujita, T.; Iwasa, J.; Hansch, C. J. Am. Chem. Soc. 1964, 86, 5175-5180.
22. 19. Yeung, J. M.; Corleto, L. A.; Knaus, E. E. J. Med. Chem. 1982, 25, 191-195.